Evidence map›Paper›PMID 25822248›Full record

ArticlePloS one2015

Warm ischemic injury is reflected in the release of injury markers during cold preservation of the human liver.

Bote G Bruinsma, Wilson Wu, Sinan Ozer, Adam Farmer, James F Markmann, Heidi Yeh, Korkut Uygun

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Frontiers in physiology · 2021
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Subzero organ preservation: the dawn of a new ice age?Current opinion in organ transplantation · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Bote G BruinsmaCenter for Engineering in Medicine, Department of Surgery, Massachusetts General Hospital/ Harvard Medical School, Boston, Massachusetts, United States; Department of Surgery (Surgical Laboratory), Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Wilson WuCenter for Engineering in Medicine, Department of Surgery, Massachusetts General Hospital/ Harvard Medical School, Boston, Massachusetts, United States.
Sinan OzerCenter for Engineering in Medicine, Department of Surgery, Massachusetts General Hospital/ Harvard Medical School, Boston, Massachusetts, United States.
Adam FarmerCenter for Engineering in Medicine, Department of Surgery, Massachusetts General Hospital/ Harvard Medical School, Boston, Massachusetts, United States.
James F MarkmannTransplant Center, Massachusetts General Hospital/ Harvard Medical School, Boston, Massachusetts, United States.
Heidi YehTransplant Center, Massachusetts General Hospital/ Harvard Medical School, Boston, Massachusetts, United States.
Korkut UygunCenter for Engineering in Medicine, Department of Surgery, Massachusetts General Hospital/ Harvard Medical School, Boston, Massachusetts, United States.
Harvard University · USMassachusetts General Hospital · USAcademic Medical Center · NL

Funding

Metabolic Modeling for Cadaveric Organ ResuscitationR01DK096075 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI UYGUN, KORKUT, YEH, HEIDI · 2012 to 2022
$3.9M
Computer-aided Development of a Liver Organ Culture SystemR00DK080942 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI UYGUN, KORKUT · 2010 to 2012
$900k
Role of B Cells in Transplant ToleranceK08DK094965 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI YEH, HEIDI · 2012 to 2016
$794k
NIDDK NIH HHS K08 DK094965NIDDK NIH HHS R00 DK080942NIDDK NIH HHS R00DK080942NIDDK NIH HHS R01 DK096075NIDDK NIH HHS R01DK096075
6 · The paper itself

Abstract

backgroundLiver transplantation plays a pivotal role in the treatment of patients with end-stage liver disease. Despite excellent outcomes, the field is strained by a severe shortage of viable liver grafts. To meet high demands, attempts are made to increase the use of suboptimal livers by both pretransplant recovery and assessment of donor livers. Here we aim to assess hepatic injury in the measurement of routine markers in the post-ischemic flush effluent of discarded human liver with a wide warm ischemic range.

methodsSix human livers discarded for transplantation with variable warm and cold ischemia times were flushed at the end of preservation. The liver grafts were flushed with NaCl or Lactated Ringer's, 2 L through the portal vein and 1 L through the hepatic artery. The vena caval effluent was sampled and analyzed for biochemical markers of injury; lactate dehydrogenase (LDH), alanine transaminase (ALT), and alkaline phosphatase (ALP). Liver tissue biopsies were analyzed for ATP content and histologically (H&E) examined.

resultsThe duration of warm ischemia in the six livers correlated significantly to the concentration of LDH, ALT, and ALP in the effluent from the portal vein flush. No correlation was found with cold ischemia time. Tissue ATP content at the end of preservation correlated very strongly with the concentration of ALP in the arterial effluent (P<0.0007, R2 = 0.96).

conclusionBiochemical injury markers released during the cold preservation period were reflective of the duration of warm ischemic injury sustained prior to release of the markers, as well as the hepatic energy status. As such, assessment of the flush effluent at the end of cold preservation may be a useful tool in evaluating suboptimal livers prior to transplantation, particularly in situations with undeterminable ischemic durations.

Indexed as

Adenosine TriphosphateAdultAgedAlanine TransaminaseAspartate AminotransferasesBiomarkersCold IschemiaCryopreservationFemaleHepatic ArteryHumansLiverLiver TransplantationL-Lactate DehydrogenaseMaleMiddle AgedAdenosine TriphosphateAlanine TransaminaseAspartate AminotransferasesBiomarkersL-Lactate DehydrogenaseOrgan Preservation Solutions

Identifiers

PMID25822248
PMCPMC4378972
OpenAlexW2085080686

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.